Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$22.96 - $36.45 $251,067 - $398,580
-10,935 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$18.14 - $23.29 $198,360 - $254,676
10,935 New
10,935 $255,000

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $2.38B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Mqs Management LLC Portfolio

Follow Mqs Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mqs Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mqs Management LLC with notifications on news.